Dr. Sturtz is a board certified Medical Oncologist/Hematologist originally from Michigan. She earned a bachelor’s degree in biology from the University of Michigan in Ann Arbor, followed by a medical degree from the Tel Aviv University’s Sackler School of Medicine in Israel. Dr. Sturtz completed an Internal Medicine residency at Oregon Health Sciences University in Portland and a Hematology/Oncology fellowship at Northwestern University in Chicago, Illinois.
“Cancer genomics is transforming how we think about and treat cancer. I am focused on using the latest technologies, including next generation sequencing, to find the most precise and effective therapies for my patients. I am committed to personalized medicine in Oncology with a focus on incorporating precision medicine, targeted therapies and immune therapy into the treatment plans of my patients. I am also passionate about clinical trials and always seek out innovative clinical trials on behalf of my patients.”
Dr. Sturtz is actively engaged in cancer research at the local and national level. In addition to her clinical practice, she is also the Principal Investigator of the Colorado Cancer Research Program (CCRP), a National Cancer Institute (NCI) funded clinical trial research organization. In this role, she oversees access and implementation of oncology clinical trials at community hospitals across Colorado and Montana. Dr. Sturtz is currently on the NCI Breast Cancer Scientific Steering Committee, a representative of the NCI Breast Immuno-oncology Task Force Committee, and a member of the ECOG-ACRIN Breast Cancer Committee. She is the leader of Cancer Care Delivery Research Initiatives for the Colorado NCI Community Oncology Research Program.
Her clinical expertise is in breast cancer, lymphomas, lung cancer and gynecologic malignancies.
When she is not at work, Dr. Sturtz enjoys hiking, birding, dancing ballet, and spending time with her husband and two children.